Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2010
08/24/2010CA2345445C A composition for the prevention and/or treatment of atherosclerosis
08/24/2010CA2213560C Pharmaceutical compositions for controlled release of soluble receptors
08/19/2010WO2010093890A2 Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides)
08/19/2010WO2010093607A1 Compounds and methods for inhibiting mmp2 and mmp9
08/19/2010WO2010093434A1 Isotopologues of lenalidomide
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010092340A1 Fused pyridine and pyrazine derivatives as kinase inhibitors
08/19/2010WO2010092043A1 Phenoxy acetic acid derivatives
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010055027A3 Salts of fingolimod
08/19/2010WO2010045276A3 Azabenzimidazolones
08/19/2010WO2010026596A3 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
08/19/2010WO2009152917A3 Stabilization of the composition of a mixture
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210828 New glycolipids and synthetic method thereof as well as their synthetic intermediates, and synthetic method thereof
08/19/2010US20100210727 Hepoxilin analog enantiomers
08/19/2010US20100210717 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210670 Methods and compostions utiliziing quinazolinones
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210644 Chemical compounds
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210606 Methods and reagents for the treatment of inflammatory disorders
08/19/2010US20100210598 Toll-like receptor modulators and treatment of diseases
08/19/2010US20100210597 C21-Deoxy Ansamycin Derivatives as Antitumor Agents
08/19/2010US20100210596 Use of aminopyrimidine compounds in the treatment of immune disorders
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210568 Thyrotropin releasing hormone for therapeutic applications
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210554 Therapeutic uses of gastrin- 1 and g- pen-grgdspca
08/19/2010US20100210553 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-arg as a therapeutic agent
08/19/2010US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
08/19/2010US20100210538 Therapeutic uses of intermedin 47 and 53 peptides
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes
08/19/2010US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209527 Composition for prevention or treatment of disease associated with production of autoantibody
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209461 Purified component of blue-green algae and method of use
08/19/2010US20100209457 Pneumococcal serotype 6d
08/19/2010US20100209456 Treating neoplasms with neurotoxin
08/19/2010US20100209452 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
08/19/2010US20100209451 Compositions and Methods Related to Adenovirus Based Delivery of Antigens
08/19/2010US20100209450 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
08/19/2010US20100209437 Anti-CD3 Antibody Fromulations
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209416 Immunoassays for lamotrigine
08/19/2010US20100209359 Medicated chewing gum
08/19/2010DE102009008851A1 Transdermal system, useful for treating multiple sclerosis and Crohn's disease, comprises an immunomodulator comprising e.g. quinoline, active agent impermeable protective layer, active agent reservoir and a carrier
08/19/2010CA2789512A1 Compounds and methods for inhibiting mmp2 and mmp9
08/19/2010CA2755935A1 Hetero ring derivative
08/19/2010CA2752033A1 Antibody to cytolethal distending toxin of campylobacter jejuni
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/18/2010EP2218451A1 Use of FTS for treating malignant disorders
08/18/2010EP2217626A1 Epitope for neutralizing antibodies
08/18/2010EP2217594A2 Novel pyrimidine derivatives
08/18/2010EP2217592A1 Biphenyl derivatives as modulators of the histamine-h3 receptor useful for the treatment of disorders related thereto
08/18/2010EP2217272A1 Immunotherapeutic method for increasing groundnut tolerance in a subject
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010EP1307222B1 Non-human animal models of tolerance to hepatitis c virus immunogens
08/18/2010EP1121115B2 Pufa supplements
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010CN1717243B Papaya puree and the use of the same
08/18/2010CN101808991A Acyclic derivatives as modulators of chemokine receptor activity
08/18/2010CN101808990A Piperidine derivatives as modulators of chemokine receptor activity
08/18/2010CN101808664A Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same
08/18/2010CN101808660A Vaccine peptide combinations against cat allergy
08/18/2010CN101808651A polymer conjugate of steroid
08/18/2010CN101808532A prevention of allergy at weaning
08/18/2010CN101805763A Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity
08/18/2010CN101805749A Simulated virus based on VSIG4, preparation method and application thereof
08/18/2010CN101805413A Preparation method of ligustrum lucidum polysaccharide
08/18/2010CN101805412A Water-soluble low-molecular-weight cordyceps polysaccharide with anti-tumor activity, preparation method and application thereof
08/18/2010CN101805410A Technological method for comprehensively producing pueraria flavonid, puerarin and arrowroot starch
08/18/2010CN101805341A inhibitors of bruton's tyrosine kinase
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805298A Novel aryl- and heteroarylpiperazines
08/18/2010CN101804174A Traditional Chinese medicine preparation for treating sicca syndrome
08/18/2010CN101804155A Medicine used for treating qi and blood deficiency caused by radiotherapy and chemotherapy of tumor and postoperative body weakness
08/18/2010CN101804145A Garlic oil enteric pellet capsule and preparation method thereof
08/18/2010CN101804139A Traditional Chinese medicine composite for preventing disease
08/18/2010CN101804096A Method for extracting purified total alkaloid of strychnos nux-vomica and application thereof in pharmacy
08/18/2010CN101804086A Preparation method of fermented red ginseng product
08/18/2010CN101804082A Method for identifying cordyceps sinensis powder through microscopic dyeing
08/18/2010CN101804077A Pretreatment method of propolis effective component raw material by supercritical extraction
08/18/2010CN101804073A Preparation method of pearl producing immune reinforcing agent
08/18/2010CN101804061A New methylprednisolone tablets and crystal form and preparation method thereof
08/18/2010CN101804054A Application, preparation and preparation method of synthetic palmatine
08/18/2010CN101803531A China cryptoporus sinensis and solid cultural method and application thereof
08/18/2010CN101348516B Refining process of triamcinolone acetonide raw medicine
08/18/2010CN101129475B Extractive of humulus plants, its use and pharmaceutical composition containing the extractive
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/18/2010CN101019911B Chinese medicine composition possessing antifatigue and immunoregulation functions
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 1172